Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib.

Posada MM, Cannady EA, Payne CD, Zhang X, Bacon JA, Pak YA, Higgins JW, Shahri N, Hall SD, Hillgren KM.

Clin Transl Sci. 2017 Nov;10(6):509-519. doi: 10.1111/cts.12486. Epub 2017 Jul 27.

2.

Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling.

Posada MM, Bacon JA, Schneck KB, Tirona RG, Kim RB, Higgins JW, Pak YA, Hall SD, Hillgren KM.

Drug Metab Dispos. 2015 Mar;43(3):325-34. doi: 10.1124/dmd.114.059618. Epub 2014 Dec 12.

PMID:
25504564
3.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17.

4.

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Boczarska-Jedynak M, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Petrucci S, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, Van Broeckhoven C, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Hentati F, Farrer MJ, Ross OA; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Mov Disord. 2013 Oct;28(12):1740-4. doi: 10.1002/mds.25600. Epub 2013 Aug 2.

5.

Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human.

Williams ET, Bacon JA, Bender DM, Lowinger JJ, Guo WK, Ehsani ME, Wang X, Wang H, Qian YW, Ruterbories KJ, Wrighton SA, Perkins EJ.

Drug Metab Dispos. 2011 Dec;39(12):2305-13. doi: 10.1124/dmd.111.041335. Epub 2011 Sep 14.

PMID:
21918037
6.

Translation initiator EIF4G1 mutations in familial Parkinson disease.

Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, Kreisler A, Ross OA, Nishioka K, Soto-Ortolaza AI, Cobb SA, Melrose HL, Behrouz B, Keeling BH, Bacon JA, Hentati E, Williams L, Yanagiya A, Sonenberg N, Lockhart PJ, Zubair AC, Uitti RJ, Aasly JO, Krygowska-Wajs A, Opala G, Wszolek ZK, Frigerio R, Maraganore DM, Gosal D, Lynch T, Hutchinson M, Bentivoglio AR, Valente EM, Nichols WC, Pankratz N, Foroud T, Gibson RA, Hentati F, Dickson DW, Destée A, Farrer MJ.

Am J Hum Genet. 2011 Sep 9;89(3):398-406. doi: 10.1016/j.ajhg.2011.08.009.

7.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870.

8.

VPS35 mutations in Parkinson disease.

Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, Soto-Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Ghika J, Hentati F, Krygowska-Wajs A, Lynch T, Melamed E, Rajput A, Rajput AH, Solida A, Wu RM, Uitti RJ, Wszolek ZK, Vingerhoets F, Farrer MJ.

Am J Hum Genet. 2011 Jul 15;89(1):162-7. doi: 10.1016/j.ajhg.2011.06.001. Erratum in: Am J Hum Genet. 2011 Aug 12;89(2):347.

9.

Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.

Mata IF, Wilhoite GJ, Yearout D, Bacon JA, Cornejo-Olivas M, Mazzetti P, Marca V, Ortega O, Acosta O, Cosentino C, Torres L, Medina AC, Perez-Pastene C, Díaz-Grez F, Vilariño-Güell C, Venegas P, Miranda M, Trujillo-Godoy O, Layson L, Avello R, Dieguez E, Raggio V, Micheli F, Perandones C, Alvarez V, Segura-Aguilar J, Farrer MJ, Zabetian CP, Ross OA.

Parkinsonism Relat Disord. 2011 Sep;17(8):629-31. doi: 10.1016/j.parkreldis.2011.05.003. Epub 2011 May 31.

10.

SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.

Wider C, Vilariño-Güell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Jun;18(6):876-81. doi: 10.1111/j.1468-1331.2010.03297.x. Epub 2010 Dec 15.

PMID:
21159074
11.

LRRK2 variation and Parkinson's disease in African Americans.

Ross OA, Wilhoite GJ, Bacon JA, Soto-Ortolaza A, Kachergus J, Cobb SA, Puschmann A, Vilariño-Güell C, Farrer MJ, Graff-Radford N, Meschia JF, Wszolek ZK.

Mov Disord. 2010 Sep 15;25(12):1973-6. doi: 10.1002/mds.23163.

12.

Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier.

Zhao R, Raub TJ, Sawada GA, Kasper SC, Bacon JA, Bridges AS, Pollack GM.

Drug Metab Dispos. 2009 Jun;37(6):1251-8. doi: 10.1124/dmd.108.025064. Epub 2009 Mar 9.

13.

Genetic testing for hereditary colorectal cancer in children: long-term psychological effects.

Codori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD, Booker SV, Picarello K, Giardiello FM.

Am J Med Genet A. 2003 Jan 15;116A(2):117-28.

PMID:
12494429
14.

Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon.

Ulrich RG, Bacon JA, Brass EP, Cramer CT, Petrella DK, Sun EL.

Chem Biol Interact. 2001 May 16;134(3):251-70. Review.

PMID:
11336974
15.

Attitudes toward colon cancer gene testing: factors predicting test uptake.

Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, Brensinger JD, Johnson K, Bacon JA, Booker SV.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):345-51.

16.

Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxylic acid metabolite.

Ulrich RG, Bacon JA, Cramer CT, Petrella DK, Sun EL, Meglasson MD, Holmuhamedov E.

Toxicology. 1998 Nov 2;131(1):33-47.

PMID:
9881933
17.

Comparative in vitro effects of closantel and selected beta-ketoamide anthelmintics on a gastrointestinal nematode and vertebrate liver cells.

Bacon JA, Ulrich RG, Davis JP, Thomas EM, Johnson SS, Conder GA, Sangster NC, Rothwell JT, McCracken RO, Lee BH, Clothier MF, Geary TG, Thompson DP.

J Vet Pharmacol Ther. 1998 Jun;21(3):190-8.

PMID:
9673959
18.

Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene.

Giardiello FM, Brensinger JD, Luce MC, Petersen GM, Cayouette MC, Krush AJ, Bacon JA, Booker SV, Bufill JA, Hamilton SR.

Ann Intern Med. 1997 Apr 1;126(7):514-9.

PMID:
9092316
19.

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.

Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, Booker SV, Parker RD, Hamilton SR.

N Engl J Med. 1997 Mar 20;336(12):823-7.

20.

Evidence against genetic anticipation in familial colorectal cancer.

Tsai YY, Petersen GM, Booker SV, Bacon JA, Hamilton SR, Giardiello FM.

Genet Epidemiol. 1997;14(4):435-46.

PMID:
9271715
21.

Potentiation of hypoxic injury in cultured rabbit hepatocytes by the quinoxalinone anxiolytic, panadiplon.

Bacon JA, Cramer CT, Petrella DK, Sun EL, Ulrich RG.

Toxicology. 1996 Apr 15;108(1-2):9-16.

PMID:
8644122
22.

Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development.

Ulrich RG, Bacon JA, Cramer CT, Peng GW, Petrella DK, Stryd RP, Sun EL.

Toxicol Lett. 1995 Dec;82-83:107-15. Review.

PMID:
8597037
23.

Comparative mutagenicity testing of ceftiofur sodium. II. Cytogenetic damage induced in vitro by ceftiofur is reversible and is due to cell cycle delay.

Aaron CS, Yu RL, Bacon JA, Kirkland D, McEnaney S, Marshall R.

Mutat Res. 1995 Nov;345(1-2):37-47. No abstract available.

PMID:
8524354
24.

Induction of a hepatic toxic syndrome in the Dutch-belted rabbit by a quinoxalinone anxiolytic.

Ulrich RG, Bacon JA, Branstetter DG, Cramer CT, Funk GM, Hunt CE, Petrella DK, Sun EL.

Toxicology. 1995 Apr 12;98(1-3):187-98.

PMID:
7740546
25.

Nucleotides-induced cytosolic calcium transient and plasma membrane permeability in Chang human liver cells.

Holmuhamedov EL, Bacon JA, Ulrich RG.

Biochem Mol Biol Int. 1995 Mar;35(3):595-604.

PMID:
7773194
26.

In vitro assessment of trospectomycin and gentamicin sulphate in the LLC-PK(1) cell line.

Bacon JA, Weaver RJ, Raczniak TJ.

Toxicol In Vitro. 1991;5(5-6):473-8.

PMID:
20732059
27.
28.

Iodine in milk and meat of dairy cows fed different amounts of potassium iodide or ethylenediamine dihydroiodide.

Swanson EW, Miller JK, Mueller FJ, Patton CS, Bacon JA, Ramsey N.

J Dairy Sci. 1990 Feb;73(2):398-405.

29.

In vitro cytotoxicity of tetracyclines and aminoglycosides in LLC-PK(1), MDCK and Chang continuous cell lines.

Bacon JA, Linseman DA, Raczniak TJ.

Toxicol In Vitro. 1990;4(4-5):384-8.

PMID:
20702199
30.

The Iodine Concentration of Market Milk in Tennessee, 1981-1986.

Holt HC, Demott BJ, Bacon JA.

J Food Prot. 1989 Feb;52(2):115-118. doi: 10.4315/0362-028X-52.2.115.

PMID:
30991478
31.
33.

Hospital-associated malnutrition.

Weinsier RL, Bacon JA, Butterworth CE Jr.

Ala J Med Sci. 1982 Oct;19(4):402-8. No abstract available.

PMID:
7181040
34.
35.

Effects of supplemental selenium on swine. II. Growing-finishing.

Wilkinson JE, Bell MC, Bacon JA, Melton CC.

J Anim Sci. 1977 Feb;44(2):229-33. No abstract available.

PMID:
833061
36.

Effects of supplemental selenium on swine. I. Gestation and lactation.

Wilkinson JE, Bell MC, Bacon JA, Masincupp FB.

J Anim Sci. 1977 Feb;44(2):224-8. No abstract available.

PMID:
833060
37.

Editorial: Anticoagulation. 3. Anticoagulation and acute myocardial infarction. "What the big boys do".

Bacon JA.

Med Ann Dist Columbia. 1974 May;43(5):7-8. No abstract available.

PMID:
4526563
38.

A convenient method for removal of radioactive contamination in particulate form.

Bacon JA, Wade L Jr.

Health Phys. 1972 Dec;23(6):855. No abstract available.

PMID:
4641339
39.

Long-term observations of skin grafts between chimeric cattle twins.

Stone WH, Cragle RG, Johnson DF, Bacon JA, Bendel S, Korda N.

Transplantation. 1971 Dec;12(6):421-8. No abstract available.

PMID:
4941046
40.

Radioiodine absorption and secretion by the calf abomasum.

Miller JK, Chandler PT, Cragle RG, Bacon JA, Wykoff MH.

J Dairy Sci. 1971 Mar;54(3):397-400. No abstract available.

41.

Absorption of 45Ca and 89Sr from the abomasum of the calf.

Chandler PT, Cragle RG, Bacon JA, Wykoff MH.

Proc Soc Exp Biol Med. 1969 Apr;130(4):1257-9. No abstract available.

PMID:
5780010
42.

Effects of large doses of orally ingested strontium-90 on young cattle.

Cragle RG, Stone WH, Bacon JA, Wykoff MH.

Radiat Res. 1969 Feb;37(2):415-22. No abstract available.

PMID:
5765550
43.

Two improved & inexpensive systems for moisture stabilization in seeds or other tissues.

Osborne TS, Bacon JA.

Plant Physiol. 1961 May;36(3):309-12. No abstract available.

44.

Radiosensitivity of seeds. I. Reduction or stimulation of seeding growth as a function of gamma-ray dose.

OSBORNE TS, BACON JA.

Radiat Res. 1960 Nov;13:686-90. No abstract available.

PMID:
13731391
45.

Influence of excessive amounts of vit. D3 on strontium-89 metabolism in the rat.

MRAZ FR, BACON JA.

Proc Soc Exp Biol Med. 1960 May;104:1-3. No abstract available.

PMID:
14424854
46.

The effect of vitamin D upon bone mineralization of Ca45 and Sr89 as chlorides and as phosphopeptides.

PATRICK H, BACON JA.

J Biol Chem. 1957 Oct;228(2):569-72. No abstract available.

47.

Some effects of parathyroid extract and cortisone on metabolism of strontium and calcium.

BACON JA, HANSARD SL, PATRICK H.

Proc Soc Exp Biol Med. 1956 Nov;93(2):349-51. No abstract available.

PMID:
13379508

Supplemental Content

Loading ...
Support Center